Healthcare Services Group (HCSG)
(Delayed Data from NSDQ)
$11.00 USD
-0.22 (-1.96%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $10.99 -0.01 (-0.09%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
Income Statements
Fiscal Year end for Healthcare Services Group, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,671 | 1,690 | 1,642 | 1,760 | 1,841 |
Cost Of Goods | 1,457 | 1,496 | 1,415 | 1,492 | 1,613 |
Gross Profit | 215 | 194 | 227 | 268 | 228 |
Selling & Adminstrative & Depr. & Amort Expenses | 167 | 140 | 173 | 151 | 150 |
Income After Depreciation & Amortization | 48 | 54 | 54 | 117 | 78 |
Non-Operating Income | 13 | -5 | 9 | 13 | 11 |
Interest Expense | 8 | 3 | 1 | 1 | 3 |
Pretax Income | 53 | 45 | 62 | 129 | 85 |
Income Taxes | 15 | 10 | 16 | 31 | 21 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 38 | 35 | 46 | 99 | 65 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 38 | 35 | 46 | 99 | 65 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 64 | 71 | 71 | 133 | 93 |
Depreciation & Amortization (Cash Flow) | 16 | 18 | 17 | 16 | 15 |
Income After Depreciation & Amortization | 48 | 54 | 54 | 117 | 78 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 74.34 | 74.35 | 74.96 | 74.79 | 74.59 |
Diluted EPS Before Non-Recurring Items | 0.76 | 0.47 | 0.61 | 1.32 | 0.87 |
Diluted Net EPS (GAAP) | 0.52 | 0.47 | 0.61 | 1.32 | 0.87 |
Fiscal Year end for Healthcare Services Group, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 423.84 | 411.39 | 418.93 | 417.23 |
Cost Of Goods | NA | 350.38 | 377.55 | 367.73 | 360.98 |
Gross Profit | NA | 73.46 | 33.83 | 51.20 | 56.25 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 46.25 | 39.05 | 41.43 | 40.05 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 27.21 | -5.22 | 9.77 | 16.20 |
Non-Operating Income | NA | 5.89 | 0.39 | 3.55 | 3.10 |
Interest Expense | NA | 2.06 | 2.13 | 1.92 | 1.75 |
Pretax Income | NA | 31.04 | -6.95 | 11.41 | 17.56 |
Income Taxes | NA | 8.44 | -1.46 | 2.81 | 4.87 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 22.60 | -5.49 | 8.60 | 12.68 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 22.60 | -5.49 | 8.60 | 12.68 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 73.88 | 74.36 | 74.57 | 74.52 |
Diluted EPS Before Non-Recurring Items | NA | 0.20 | 0.17 | 0.12 | 0.17 |
Diluted Net EPS (GAAP) | NA | 0.30 | -0.07 | 0.12 | 0.17 |